The LightOn project is the result of a longstanding and interdisciplinary collaboration between the inventors on optical information processing.

Alexander von Gabain, the new innovation leader at Karolinska Institutet, pushes the famed medical school to bring more companies, entrepreneurs and investment on campus

A new Science|Business report analyses the principles and strategies that lie at the heart of one of the world’s most productive tech transfer offices, Leuven Research and Development

As the first World Antibiotics Awareness week has highlighted, the traditional business model for antibiotics is broken. Incentives are required to promote development of new products, says Luke Moore. What about a lump sum payment?

An Imperial team is carrying out research to help with the clean-up of nuclear waste following the Fukushima nuclear accident in Japan.

Over the last few weeks, CERN's nuclear physics facility, ISOLDE, has been producing ion beams at higher energies. The first cryomodule of the new HIE-ISOLDE (High-Intensity and Energy ISOLDE) accelerator is up and running, increasing the beam energy from 3 to 4.3 MeV per nucleon.

An improved gene therapy treatment can cure mice with cystic fibrosis (CF). Cell cultures from CF patients, too, respond well to the treatment. Those are the encouraging results of a study presented by the KU Leuven Laboratory for Molecular Virology and Gene Therapy.

Partnership with IBM will equip researchers with ethical guidelines to using big data

A major showcase of companies developing new technologies from graphene and other two-dimensional materials took place this week at the Cambridge Graphene Centre

Two leaders at King’s - Deborah Bull and Professor Louise Archer – have joined the British Science Association Board of Trustees, in recognition of their work to the science community.